logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Sylvain Dureau

Institut Curie
H指数:18
被引数:1,436

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A prospective trial for breast cancer diagnosis by canine odorology

一项关于利用犬嗅觉学进行乳腺癌诊断的前瞻性试验

Nature Communications
IF15.7
2025-11-270
OAAI
Anne Tardivon; Benoit Mesurolle; Sylvain Dureau; Edouard Poncelet; François Dravet; Adriana Langer; Marie-Rose El Bejjani; Séverine Alran; Elise Deluche; Alexia Savignoni; Amir Kadi; Pierre Bauër; Caroline Gilbert; Michelle Leemans; Isabelle Fromantin
Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trial

对于新诊断的多发性转移性尤因肉瘤患者，采用序贯多模式治疗方法的临床价值：法国前瞻性CombinaiR3 II期试验结果

British Journal of Cancer
IF6.8
2025-11-170
PRE
Valérie Laurence; Nina Jehanno; Sylvain Dureau; Lieke Mous; Line Claude; Stelly Ballet; Gaëlle Pierron; Nathalie Gaspar; Mehdi Brahmi; Thibaud Valentin; Gabriel Revon-Rivière; Cyril Lervat; Jamie Probert; Natacha Entz-Werle; Ludovic Mansuy; Dominique Plantaz; Maria Rios; Laure Saumet; Cécile Vérité; Marie-Pierre Castex; Estelle Thebaud; Thibaut Cassou-Mounat; Anne-Sophie Plissonnier; Jennifer Dieppedale; Olivier Delattre; Marie-Emmanuelle Legrier; Perrine Marec-Bérard; François Gouin; Pablo Berlanga; Camille Cordero; Didier Surdez; Nadège Corradini
Multimodal therapy in first line treatment of very high risk Ewing sarcoma patients: Results of the French prospective multicenter COMBINAIR3 phase II trial

多模态疗法在超高危尤因肉瘤患者一线治疗中的应用：法国前瞻性多中心COMBINAIR3 II期试验的结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Laurence, V.; Cordero, C.; Dureau, S.; Jehanno, N.; Pierron, G.; Gaspar, N.; Valentin, T.; Revon-Riviere, G.; Lervat, C.; Taque, S.; Entz-Werle, N.; Mansuy, L.; Plantaz, D.; Rios, M.; Saumet, L.; Verite, C.; Castex, M-P.; Thebaud, E.; Brahmi, M.; Corradini, N.
Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial
EUROPEAN JOURNAL OF CANCER
IF7.1
2023-04-0116
OAAI
Hilmi, Marc; Kamal, Maud; Vacher, Sophie; Dupain, Celia; Ibadioune, Sabrina; Halladjian, Maral; Sablin, Marie Paule; Marret, Gregoire; Ajgal, Zahra Castel; Nijnikoff, Michele; Salomon, Anne; El Beaino, Zakhia; Servant, Nicolas; Dureau, Sylvain; Sokol, Harry; Nicolle, Remy; Le Tourneau, Christophe; Bieche, Ivan; Neuzillet, Cindy
Circulating Tumor Cells-driven choice of first line therapy for ER+HER2-metastatic breast cancer: overall survival analysis of the randomized STIC CTC trial
CANCER RESEARCH
IF16.6
2023-03-010
PRE
Bidard, Francois-Clement; Kiavue, Nicolas; Alix-Panabieres, Catherine; Dureau, Sylvain; Bachelot, Thomas; Bourgeois, Hugues; Goncalves, Anthony; Brain, Etienne; Ladoire, Sylvain; Dalenc, Florence; Gligorov, Joseph; Teixeira, Luis; Emile, George; Ferrero, Jean-Marc; Loirat, Delphine; Cabel, Luc; Dieras, Veronique; Berger, Frederique; Jacot, William; Pierga, Jean-Yves
Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study
BLOOD ADVANCES
IF7.1
2022-08-1814
OAAI
Lesueur, Paul; Damaj, Gandhi; Hoang-Xuan, Khe; Roland, Virginie; Schmitt, Anna; Chinot, Olivier; Fabbro, Michel; Agape, Philippe; Molucon-Chabrot, Cecile; Chebrek, Safia; Alentorn, Agusti; Feuvret, Loic; Delgadillo, Daniel; Stefan, Dinu; Choquet, Sylvain; Nichelli, Lucia; Mokhtari, Karima; Mathon, Bertrand; Dureau, Sylvain; Soussain, Carole; Houillier, Caroline
Survival outcomes after neoadjuvant letrozole and palbociclib versus third generation chemotherapy for patients with high-risk oestrogen receptor-positive HER2-negative breast cancer

来曲唑和帕博西尼新辅助化疗与第三代化疗对高危雌激素受体阳性HER2-negative乳腺癌患者的生存结果

EUROPEAN JOURNAL OF CANCER
IF7.1
2022-05-0119
OAAI
Delaloge, Suzette; Dureau, Sylvain; D'Hondt, Veronique; Desmoulins, Isabelle; Heudel, Pierre-Etienne; Duhoux, Francois P.; Levy, Christelle; Lerebours, Florence; Mouret-Reynier, Marie A.; Dalenc, Florence; Frenel, Jean-Sebastien; Jouannaud, Christelle; Venat-Bouvet, Laurence; Nguyen, Suzanne; Callens, Cecile; Gentien, David; Rapinat, Audrey; Manduzio, Helene; Vincent-Salomon, Anne; Lemonnier, Jerome; Cottu, Paul
Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer
CLINICAL CANCER RESEARCH
IF10.2
2021-07-0149
OAAI
Jeannot, Emmanuelle; Latouche, Aurelien; Bonneau, Claire; Calmejane, Marie-Ange; Beaufort, Corine; Ruigrok-Ritstier, Kirsten; Bataillon, Guillaume; Cherif, Linda Larbi; Dupain, Celia; Lecerf, Charlotte; Popovic, Marina; de la Rochefordiere, Anne; Lecuru, Fabrice; Fourchotte, Virginie; Jordanova, Ekaterina S.; von der Leyen, Heiko; Tran-Perennou, Carine; Legrier, Marie-Emmanuelle; Dureau, Sylvain; Raizonville, Laurence; Roufai, Diana Bello; Le Tourneau, Christophe; Bieche, Ivan; Rouzier, Roman; Berns, Els M. J. J.; Kamal, Maud; Scholl, Suzy
Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome (vol 43, pg 253, 2019)
EBIOMEDICINE
IF10.8
2020-07-012
OAAI
Scholl, Suzy; Popovic, Marina; de la Rochefordiere, Anne; Girard, Elodie; Dureau, Sylvain; Mandic, Aljosa; Koprivsek, Katarina; Samet, Nina; Craina, Marius; Margan, Madalin; Samuels, Sanne; Zijlmans, Henry; Kenter, Gemma; Hillemanns, Peter; Dema, Sorin; Dema, Alis; Malenkovic, Goran; Djuran, Branislav; Floquet, Anne; Garbay, Delphine; Guyon, Federic; Colombo, Pierre Emmanuel; Fabbro, Michel; Kerr, Christine; Ngo, Charlotte; Lecuru, Fabrice; del Campo, Eleonor Rivin; Coutant, Charles; Marchal, Frederic; Mesgouez-Nebout, Nathalie; Fourchotte, Virginie; Feron, Jean Guillaume; Morice, Philippe; Deutsch, Eric; Wimberger, Pauline; Classe, Jean-Marc; Gleeson, Noreen; von der Leyen, Heiko; Minsat, Mathieu; Dubot, Coraline; Gestraud, Pierre; Kereszt, Attila; Nagy, Istvan; Balint, Balazs; Berns, Els; Jordanova, Ekaterina; de Saint-Jorre, Nicolas; Savignoni, Alexia; Servant, Nicolas; Hupe, Philippe; de Koning, Leanne; Fumoleau, Pierre; Rouzier, Roman; Kamal, Maud
Circulating tumor cells as a tool to guide first line therapy in metastatic breast cancer: subgroup analyses of the STIC CTC Phase III utility trial
CANCER RESEARCH
IF16.6
2019-07-010
PRE
Bidard, Francois-Clement; Jacot, William; Dureau, Sylvain; Brain, Etienne; Bachelot, Thomas; Bourgeois, Hugues; Goncalves, Anthony; Ladoire, Sylvain; Naman, Herve; Dalenc, Florence; Gligorov, Joseph; Espie, Marc; Levy, Christelle; Ferrero, Jean-Marc; Loirat, Delphine; Cottu, Paul; Dieras, Veronique; Legrier, Marie-Emmanuelle; Berger, Frederique; Alix-Panabieres, Catherine; Pierga, Jean-Yves

研究方向

暂未获取到该数据
F
Frédérique Berger
H 指数:25论文数:129被引数:2,164
A
Anne Vincent‐Salomon
H 指数:110论文数:1,076被引数:6.6万
F
Florence Dalenc
H 指数:55论文数:561被引数:1.6万
C
Christelle Lévy
H 指数:46论文数:389被引数:1.0万
D
Delphine Loirat
H 指数:39论文数:304被引数:7,330
N
Nicolas Servant
H 指数:49论文数:271被引数:1.6万
M
Maud Kamal
H 指数:38论文数:281被引数:6,221
P
Paul Cottu
H 指数:53论文数:529被引数:1.0万
A
Aline Albi-Feldzer
H 指数:8论文数:24被引数:404
J
Jean‐Yves Pierga
H 指数:79论文数:719被引数:2.9万